Bayer completed the acquisition of Monsanto today following the receipt of all required approvals from regulatory authorities. 

Bayer is now the sole owner of Monsanto Company. According to the conditional approval from the United States Department of Justice (DOJ), the integration of Monsanto into Bayer can take place as soon the divestments to BASF have been completed.

This integration process is expected to commence in approximately two months. Liam Condon, member of the Bayer Board of Management, will lead the combined Crop Science division when the integration commences.

“The acquisition of Monsanto is a strategic milestone in strengthening our portfolio of leading businesses in health and nutrition," stated Werner Baumann, Chairman of the Board of Management of Bayer AG. "We will double the size of our current business with a truly excellent combination of talent, technologies and customer reach. As a future leader in this space, we at Bayer will have a special responsibility. And we will do everything we can to live up to this responsibility. We will uphold the highest ethical, environmental and social standards, engage all stakeholders, and contribute to better and more sustainable agriculture.”